Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

77 ELEKTRONIKA

Develops, manufactures, and markets fully automated and semi-automated urine analyzers, blood glucose meters, rapid t... read more Featured Products: More products

Download Mobile App




Automated Urine Microscope Verified for Regional Laboratories

By LabMedica International staff writers
Posted on 03 Feb 2021
Automated Urine Microscopy examines a sample of urine under a microscope. It can check cells from the urinary tract, blood cells, crystals, bacteria, parasites, and cells from tumors. This test is often used to confirm the findings of other tests or add information to a diagnosis.

Automation of urine particle counting has become a clinical standard in medium-sized and large laboratories by means of flow cytometry or several types of image analyzers. Reliable implementation of those instruments requires utilization of reference procedures in their verification.

Clinical Chemists and Microbiologists from Helsinki University Hospital (Helsinki, Finland) carried out the primary verification with 463 urine specimens, and against urine culture on chromogenic agar plates with 396 parallel specimens. Nine secondary instruments were compared pairwise with the primary instrument. Both mid-stream collections (generally 90% of all specimens) and catheterized specimens were taken into the study, based on particle findings.

Specimens were chosen from routine analysis by UF-1000i instrument (Sysmex, Kobe, Japan) for verification of the primary (“Gold”) UriSed 3 PRO instrument (77 Elektronika, Budapest, Hungary) against reference visual microscopy during a 6-week period in September - October 2018. Comparisons to urine culture results were available for 396 parallel samples which were cultured by using automated inoculation with 1 µL loop (WASP automated microbiology instrument, COPAN Wasp, Brescia, Italy) on chromogenic agar plates (CHROMagar Orientation medium, CHROMagar, Paris, France) following incubation at 35 °C for 18 hours.

The scientists reported that relative imprecisions compared to Poisson distribution, R(CV), were estimated to be 1.0 for white blood cell (WBC) and 1.5 for red blood cell (RBC) counts, respectively. Spearman’s correlations against visual microscopy were rS = 0.94 for WBC, rS = 0.87 for RBC, and rS = 0.82 for squamous epithelial cell (SEC) counts. Agreement with visual microscopy (Cohen’s weighted kappa) was 0.94 for WBC, 0.89 for RBC, 0.88 for SEC, 0.59 for combined casts, and 0.49 for non-squamous epithelial cells (NEC). Bacteria were detected with a sensitivity of 90% and specificity of 39 against culture at 107 colony forming bacteria/L (CFB/L = 104 CFU/mL). Created flagging limits allowed automated reporting for 70-75 % of patient results.

The authors were able to install 10 UriSed 3 PRO instruments in a regional laboratory environment at HUSLAB, providing about 160,000 automated particle counts annually at 24/7 basis, thus satisfying both routine testing and emergency analysis of clinical samples. Analytical performance fulfilled the analytical performance specifications and expectations obtained from preliminary testing. The study was published on January 26, 2021 in the journal Clinica Chimica Acta.

Related Links:
Helsinki University Hospital
Sysmex
77 Elektronika
COPAN Wasp
CHROMagar


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.